|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
146
|
|
pubmed:dateCreated |
1998-2-6
|
|
pubmed:abstractText |
Cysticerosis is the commonest parasitic disease to affect the central nervous system (CNS). Distribution is universal. It is endemic in many developing countries and in the Third World. CNS cysticercoses or neurocysticercosis may be classified according to its site in three main groups: parenchymatous, extra-parenchymatous and mixed. The clinical features vary from casual findings to fulminating encephalitis. The commonest presenting symptoms are intracranial hypertension (HIC) in the extra-parenchymatous forms and convulsions in the parenchymatous forms.
|
|
pubmed:language |
spa
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0210-0010
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1585-8
|
|
pubmed:dateRevised |
2009-5-28
|
|
pubmed:meshHeading |
pubmed-meshheading:9462988-Albendazole,
pubmed-meshheading:9462988-Anthelmintics,
pubmed-meshheading:9462988-Anti-Inflammatory Agents,
pubmed-meshheading:9462988-Brain Diseases,
pubmed-meshheading:9462988-Calcinosis,
pubmed-meshheading:9462988-Child,
pubmed-meshheading:9462988-Cysticercosis,
pubmed-meshheading:9462988-Dexamethasone,
pubmed-meshheading:9462988-Drug Therapy, Combination,
pubmed-meshheading:9462988-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9462988-Humans,
pubmed-meshheading:9462988-Magnetic Resonance Imaging,
pubmed-meshheading:9462988-Male,
pubmed-meshheading:9462988-Tomography, X-Ray Computed
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
[A case of mixed (parenchymatous meningo-basal) neurocysticercosis].
|
|
pubmed:affiliation |
Sección de Neurología, Hospital Niño Jesús, Madrid, España.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
